Sonoma Pharmaceuticals Inc. Live Stock Price Today, Share Analysis and Chart

Name: Sonoma Pharmaceuticals Inc.: Is Infosys Ltd. worth buying?
Item: Sonoma Pharmaceuticals Inc.
Rating: 2.44200
Author: Trendlyne DVM scores

about

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focu...

4.57 -0.16 (-3.38%)

33.96% Fall from 52W High

32,789

XNAS Volume

XNAS 08 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

25.5 / 100

Technically Bullish

72.2 / 100

1Yr Price target upside is 193%

2 analysts

Sonoma Pharmaceuticals Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Sonoma Pharmaceuticals Inc. Live Stock Price Today, Share Analysis and Chart

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focu...

33.96% Fall from 52W High

SWOT Analysis

Sonoma Pharmaceuticals Inc. Live Price Chart